Hormone Refractory Prostate Cancer

• SCRI at HCA HealthONE — Denver, Colorado, United States
• The University of Texas MD Anderson Cancer Center — Houston, Texas, United States
• NEXT Oncology — San Antonio, Texas, United States
• HonorHealth Research Institute — Scottsdale, Arizona, United States

• Institute of Cancer Research and Royal Marsden Hospital — Sutton, Surrey, United Kingdom

• Los Angeles, California, United States
• Roseville, California, United States
• Tampa, Florida, United States
• New Orleans, Louisiana, United States

• University of Alabama at Birmingham — Birmingham, Alabama, United States

• Holden Comprehensive Cancer Center — Iowa City, Iowa, United States

Not specified

• Korean Cancer Study Group — Seoul, Chongro-ku, South Korea
• Korea University Anam Hospital — Seoul, Seongbuk-gu, Inchon-ro, South Korea

• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Nebraska Methodist Hospital — Omaha, Nebraska, United States
• University of Texas M.D. Anderson Cancer Center — Houston, Texas, United States

• Dana-Farber Cancer Institute (DFCI) — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center (BIDMC) — Boston, Massachusetts, United States
• Memorial Sloan-Kettering Cancer Center — New York, United States
• MSKCC- Sidney Kimmel Center — New York, United States

• UCSD Medical Center - La Jolla — La Jolla, California, United States
• Moores UCSD Cancer Center — La Jolla, California, United States
• Cancer Center Oncology Medical Group — La Mesa, California, United States
• UCSD Medical Center - Hillcrest — San Diego, California, United States